Skip to main content

Land & Buildings Issues White Paper Detailing Impact of Work From Home Trend On Life Science Office Market

Analysis Shows Employee Attendance in Life Science Buildings with a Combination of Laboratory and Office Space Down 50% Compared to Pre-Pandemic Levels – On Par With Traditional Office Buildings

Following an In-Depth Analysis of Alexandria Real Estate Equities’ Portfolio, Land & Buildings Predicts Shares Could See ~30-40% Downside From Current Levels

Land & Buildings Investment Management, LLC (together with its affiliates, “Land & Buildings”, “us” or “we”), today issued a white paper titled The Work From Home Hurricane Has Hit Life Science Offices, detailing the impact of COVID-19 on the life science office market. Specifically, Land & Buildings’ analysis focused on life science REIT company Alexandria Real Estate Equities, Inc. (NYSE: ARE).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230616782160/en/

With typically 50% laboratory space and 50% office space, many observers have considered companies with office exposure in the life science sector as a safe haven from the impact of the work-from-home phenomenon. Unfortunately, Land & Buildings’ analysis starkly contradicts this view. The full white paper can be found here.

Land & Buildings’ study concludes that if the path for life science follows traditional office, as it appears to be doing, Land & Buildings estimates ARE could trade at valuations similar to traditional coastal office REITs – which suggests an approximate 30-40% downside from current levels.

Previously, in May 2020, Land & Buildings published a white paper titled The New York Office Market is Facing an Existential Hurricane.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.54
-3.65 (-1.61%)
AAPL  274.11
-4.17 (-1.50%)
AMD  207.58
-3.20 (-1.52%)
BAC  55.33
+0.19 (0.34%)
GOOG  309.32
-1.20 (-0.39%)
META  647.51
+3.28 (0.51%)
MSFT  474.82
-3.71 (-0.78%)
NVDA  176.29
+1.27 (0.73%)
ORCL  184.92
-5.05 (-2.66%)
TSLA  475.31
+16.35 (3.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.